Compare Appian Corp (APPN) vs Charles River Laboratories Intl. Inc (CRL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Appian Corp vs Charles River Laboratories Intl. Inc — how do they compare? Appian Corp trades at $35.5 (market cap $2.54B), while Charles River Laboratories Intl. Inc trades at $282 (market cap $13.46B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 5.3× Appian Corp's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Appian Corp nearer its low. Which is the better fit depends on your goals.
| APPN | CRL | |
|---|---|---|
Market Cap | $2.54B | $13.46B |
Sector | Technology | Health |
52-Week High | $45.64 | $282.00 |
52-Week Low | $18.72 | $145.57 |
Enterprise Value | $2.67B | $16.30B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Appian Corp
Appian Corp provides a low-code software development platform as a service that enables organizations to rapidly develop powerful and unique applications. With its platform, organizations can rapidly and easily design, build and implement powerful, enterprise-grade custom applications through intuitive, visual interface with little or no coding required. The company's customers use applications built on its low-code platform to launch new business lines, automate vital employee workflows, manage complex trading platforms, accelerate drug development and build procurement systems. The group generates a majority of its revenue from the domestic market. It serves various industries such as education.
Read more on APPN →About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →
